首页 > 最新文献

Obstetrics and Gynecology Science最新文献

英文 中文
Robotic sacrocolpopexy. 机器人骶骨整形术
IF 1.9 Q2 Medicine Pub Date : 2024-03-01 Epub Date: 2024-01-18 DOI: 10.5468/ogs.23226
Al-Otaibi Mozon, Ju Hee Kim, Sa Ra Lee

Pelvic organ prolapse (POP) is a common cause of gynecological disease in elderly women. The prevalence of POP has increased with an aging society. Abdominal sacrocolpopexy (ASC) is safer and more effective than the vaginal approach in patients with apical compartment POP because it has a higher anatomical cure rate, a lower recurrence rate, less dyspareunia, and improved sexual function. Laparoscopic sacrocolpopexy (LSC) has replaced ASC. Robotic sacrocolpopexy (RSC) also helps overcome the challenges of LSC by facilitating deep pelvic dissection and multiple intracorporeal suturing. The RSC is technically easy to apply, has a steep learning curve, and offers many advantages over the LSC. However, insufficient data led us to conclude that the LSC is superior overall, especially in terms of costeffectiveness. The present review provides insights into different aspects of RSC, highlighting the most common benefits and concerns of this procedure. We searched for eligible articles discussing this issue from January 2019 to March 2022 to reveal the outcomes of RSC.

盆腔器官脱垂(POP)是老年妇女妇科疾病的常见病因。随着老龄化社会的到来,盆腔器官脱垂的发病率也在增加。腹腔镜骶尾部结扎术(ASC)比阴道法更安全、更有效,因为腹腔镜骶尾部结扎术解剖学治愈率更高、复发率更低、排便困难更少、性功能更佳。腹腔镜骶尾部结扎术(LSC)已经取代了腹腔镜骶尾部结扎术。机器人骶尾部结扎术(RSC)也有助于克服腹腔镜骶尾部结扎术的挑战,因为它便于盆腔深部解剖和多次体腔内缝合。RSC 在技术上易于应用,学习曲线陡峭,与 LSC 相比具有很多优势。然而,由于数据不足,我们得出结论认为 LSC 总体上更具优势,尤其是在成本效益方面。本综述深入探讨了 RSC 的各个方面,重点介绍了该手术最常见的优点和问题。我们搜索了2019年1月至2022年3月期间讨论该问题的符合条件的文章,以揭示RSC的结果。
{"title":"Robotic sacrocolpopexy.","authors":"Al-Otaibi Mozon, Ju Hee Kim, Sa Ra Lee","doi":"10.5468/ogs.23226","DOIUrl":"10.5468/ogs.23226","url":null,"abstract":"<p><p>Pelvic organ prolapse (POP) is a common cause of gynecological disease in elderly women. The prevalence of POP has increased with an aging society. Abdominal sacrocolpopexy (ASC) is safer and more effective than the vaginal approach in patients with apical compartment POP because it has a higher anatomical cure rate, a lower recurrence rate, less dyspareunia, and improved sexual function. Laparoscopic sacrocolpopexy (LSC) has replaced ASC. Robotic sacrocolpopexy (RSC) also helps overcome the challenges of LSC by facilitating deep pelvic dissection and multiple intracorporeal suturing. The RSC is technically easy to apply, has a steep learning curve, and offers many advantages over the LSC. However, insufficient data led us to conclude that the LSC is superior overall, especially in terms of costeffectiveness. The present review provides insights into different aspects of RSC, highlighting the most common benefits and concerns of this procedure. We searched for eligible articles discussing this issue from January 2019 to March 2022 to reveal the outcomes of RSC.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948206/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139513597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of trigger day serum luteinising hormone levels on the in-vitro fertilization outcome: an observational study. 触发日血清黄体生成素水平对试管婴儿结果的影响:一项观察性研究。
IF 1.9 Q2 Medicine Pub Date : 2024-03-01 Epub Date: 2024-02-07 DOI: 10.5468/ogs.23215
Harpreet Kaur, Gautham T Pranesh, Vyshnavi Rao, Kamini A Rao

Objective: Controlled ovarian stimulation leads to profound changes in the endocrine characteristics of the ovarian cycle. Serum luteinising hormone (LH) levels on the day of trigger have been shown to correlate with oocyte quality and pregnancy rate in antagonist cycles.

Methods: This is an observational study of 86 women undergoing an antagonist in-vitro fertilisation cycle. Oocyte maturation trigger used was either Inj. human chorionic gonadotropin or Inj. triptorelin 0.2 mg s/c or a combination of both. Women were categorised into four groups based on serum LH levels on the day of trigger i.e., LH ≤0.5 (n=8), LH=0.6- 1.0 international units (IU)/L (n=12), LH=1.0-1.5 IU/L (n=13), and LH >1.6 IU/L (n=53) and the subgroup analysis was done based on type of trigger used.

Results: Mature oocyte (MII) retrieval rate did not show a significant relation with serum LH levels (87%, 89%, 77%, and 76% in groups with LH <0.5, 0.5-1.0, 1.0-1.5, and >1.5 IU/L respectively; P-value=0.243). There was no significant difference in the clinical pregnancy rate either when women were split according to the type of trigger given or according to trigger day LH levels. Women with low LH levels (<0.5 IU/L) required significantly more doses of gonadotropins compared to women with LH levels of 1.0-1.5 IU/L. (3,531+1,133 vs. 2,281+938; P-value=0.01).

Conclusion: Based on the observation from the current study, there was no significant association of serum LH levels with MII retrieval rate and clinical pregnancy rate. The group with low LH levels required slightly longer days of stimulation.

目的:控制性卵巢刺激会导致卵巢周期的内分泌特征发生剧烈变化。在拮抗剂周期中,触发卵巢刺激日的血清黄体生成素(LH)水平与卵母细胞质量和妊娠率相关:这项观察性研究的对象是在印度一家三级试管婴儿医院接受拮抗剂体外受精(IVF)周期治疗的 86 名妇女,她们的适应症各不相同。为了促使卵母细胞成熟,主治医生决定注射人绒毛膜促性腺激素或曲普瑞林 0.2 mg/s/c,或两者的组合。根据触发当天的血清 LH 水平,妇女被分为四组,即 LH ≤0.5 IU/L (人数=08)、LH=0.6-1.0 IU/L (人数=12)、LH=1.0-1.5 IU/L (人数=13)和 LH >1.6 IU/L (人数=53)。根据所使用的触发器类型进行了分组分析:成熟卵母细胞(MII)获取率与血清 LH 水平无显著相关性(LH 为 1.5 IU/L 的组别中,成熟卵母细胞获取率为 87%;P=0.243)。LH水平低(触发日为1.5 IU/L)的妇女(五分之四报告流产):我们的研究结果表明,血清 LH 水平、MII 取卵率和临床妊娠率之间没有明显的关联。低 LH 水平组所需的刺激天数稍长,而在触发日 LH 水平大于 1.5 IU/L 的妇女中,流产次数有增加的趋势。
{"title":"Effect of trigger day serum luteinising hormone levels on the in-vitro fertilization outcome: an observational study.","authors":"Harpreet Kaur, Gautham T Pranesh, Vyshnavi Rao, Kamini A Rao","doi":"10.5468/ogs.23215","DOIUrl":"10.5468/ogs.23215","url":null,"abstract":"<p><strong>Objective: </strong>Controlled ovarian stimulation leads to profound changes in the endocrine characteristics of the ovarian cycle. Serum luteinising hormone (LH) levels on the day of trigger have been shown to correlate with oocyte quality and pregnancy rate in antagonist cycles.</p><p><strong>Methods: </strong>This is an observational study of 86 women undergoing an antagonist in-vitro fertilisation cycle. Oocyte maturation trigger used was either Inj. human chorionic gonadotropin or Inj. triptorelin 0.2 mg s/c or a combination of both. Women were categorised into four groups based on serum LH levels on the day of trigger i.e., LH ≤0.5 (n=8), LH=0.6- 1.0 international units (IU)/L (n=12), LH=1.0-1.5 IU/L (n=13), and LH >1.6 IU/L (n=53) and the subgroup analysis was done based on type of trigger used.</p><p><strong>Results: </strong>Mature oocyte (MII) retrieval rate did not show a significant relation with serum LH levels (87%, 89%, 77%, and 76% in groups with LH <0.5, 0.5-1.0, 1.0-1.5, and >1.5 IU/L respectively; P-value=0.243). There was no significant difference in the clinical pregnancy rate either when women were split according to the type of trigger given or according to trigger day LH levels. Women with low LH levels (<0.5 IU/L) required significantly more doses of gonadotropins compared to women with LH levels of 1.0-1.5 IU/L. (3,531+1,133 vs. 2,281+938; P-value=0.01).</p><p><strong>Conclusion: </strong>Based on the observation from the current study, there was no significant association of serum LH levels with MII retrieval rate and clinical pregnancy rate. The group with low LH levels required slightly longer days of stimulation.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139703664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical relevance of vaginal natural orifice transluminal endoscopic surgery (vNOTES) in gynecology. 妇科阴道自然孔腔镜内窥镜手术(vNOTES)的临床意义。
IF 1.9 Q2 Medicine Pub Date : 2024-03-01 Epub Date: 2024-01-16 DOI: 10.5468/ogs.23205
Jung Chul Kim, Ga Won Yim, Young Tae Kim

This study reviews the progress and recent advances in vaginal natural orifice transluminal endoscopic surgery (vNOTES) as a minimally invasive gynecologic procedure. The proposed advantages of vaginal natural orifice transluminal surgery include enhanced cosmesis due to a scarless procedure, better exposure compared with the pure vaginal approach, tolerable pain scores, fewer perioperative complications, and a shorter hospital stay. Recent advances in surgical instrumentation and technology have improved the feasibility of vNOTES as an innovative treatment option for gynecological conditions. However, technical challenges and training issues must be overcome before its widespread use. As a promising surgical innovation, further randomized comparative studies are required to clarify the safety and effectiveness of vNOTES in gynecology.

本研究回顾了阴道自然腔道内窥镜手术(vNOTES)作为微创妇科手术的进展和最新进展。阴道自然孔腔镜手术的优点包括:无疤痕手术改善了外观;与纯阴道手术相比,暴露效果更好;疼痛评分可耐受;围手术期并发症少;住院时间短。手术器械和技术的最新进展提高了 vNOTES 作为妇科疾病创新治疗方案的可行性。然而,在广泛应用之前,还必须克服技术挑战和培训问题。作为一种前景广阔的外科创新技术,还需要进一步的随机对比研究来明确vNOTES在妇科领域的安全性和有效性。
{"title":"Clinical relevance of vaginal natural orifice transluminal endoscopic surgery (vNOTES) in gynecology.","authors":"Jung Chul Kim, Ga Won Yim, Young Tae Kim","doi":"10.5468/ogs.23205","DOIUrl":"10.5468/ogs.23205","url":null,"abstract":"<p><p>This study reviews the progress and recent advances in vaginal natural orifice transluminal endoscopic surgery (vNOTES) as a minimally invasive gynecologic procedure. The proposed advantages of vaginal natural orifice transluminal surgery include enhanced cosmesis due to a scarless procedure, better exposure compared with the pure vaginal approach, tolerable pain scores, fewer perioperative complications, and a shorter hospital stay. Recent advances in surgical instrumentation and technology have improved the feasibility of vNOTES as an innovative treatment option for gynecological conditions. However, technical challenges and training issues must be overcome before its widespread use. As a promising surgical innovation, further randomized comparative studies are required to clarify the safety and effectiveness of vNOTES in gynecology.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139472991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vulval premalignant lesions: a review article. 外阴癌前病变:综述文章。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-03-01 Epub Date: 2024-01-23 DOI: 10.5468/ogs.23274
Sumedha Gupta, Sana Ahuja, Dheer Singh Kalwaniya, Saritha Shamsunder, Shalu Solanki

Vulvar intraepithelial neoplasia (VIN) is a noninvasive squamous lesion that is a precursor of vulvar squamous cell cancer. Currently, no screening tests are available for detecting VIN, and a biopsy is performed to confirm the clinical diagnosis. Despite sharing many risk factors with cervical intraepithelial neoplasia, the diagnosis of VIN is poses challenges, contributing to its increasing prevalence. This study aimed to analyze the underlying risk factors that contribute to the development of VIN, identify specific populations at risk, and define appropriate treatment approaches. Differentiated VIN (dVIN) and usual VIN (uVIN) are the classifications of VIN. While dVIN is associated with other vulvar inflammatory disorders, such as lichen sclerosis, the more prevalent uVIN is associated with an underlying human papillomavirus infection. Patients with differentiated VIN have an increased risk of developing invasive malignancies. Few effective surveillance or management techniques exist for vulvar intraepithelial neoplasia, a preinvasive neoplasm of the vulva. For suspicious lesions, a thorough examination and focused biopsy are necessary. Depending on the specific needs of each patient, a combination of surgical and medical approaches can be used.

外阴上皮内瘤变(VIN)是一种非侵入性鳞状病变,是外阴鳞状细胞癌的前兆。目前还没有检测 VIN 的筛查试验,需要进行活组织检查来确诊。尽管外阴鳞状细胞癌与宫颈上皮内瘤变有许多共同的风险因素,但其诊断仍面临挑战,这也是其发病率不断上升的原因之一。本研究旨在分析导致 VIN 发生的潜在风险因素,识别特定高危人群,并确定适当的治疗方法。分化型 VIN(dVIN)和普通型 VIN(uVIN)是 VIN 的分类。分化型外阴阴道炎(dVIN)与其他外阴炎症性疾病(如苔藓硬化症)有关,而更常见的普通型外阴阴道炎(uVIN)则与潜在的人类乳头瘤病毒感染有关。分化型 VIN 患者罹患侵袭性恶性肿瘤的风险更高。外阴上皮内瘤变是外阴的一种浸润性肿瘤,目前几乎没有有效的监测或管理技术。对于可疑病变,必须进行彻底检查和重点活检。根据每位患者的具体需求,可采用手术和药物治疗相结合的方法。
{"title":"Vulval premalignant lesions: a review article.","authors":"Sumedha Gupta, Sana Ahuja, Dheer Singh Kalwaniya, Saritha Shamsunder, Shalu Solanki","doi":"10.5468/ogs.23274","DOIUrl":"10.5468/ogs.23274","url":null,"abstract":"<p><p>Vulvar intraepithelial neoplasia (VIN) is a noninvasive squamous lesion that is a precursor of vulvar squamous cell cancer. Currently, no screening tests are available for detecting VIN, and a biopsy is performed to confirm the clinical diagnosis. Despite sharing many risk factors with cervical intraepithelial neoplasia, the diagnosis of VIN is poses challenges, contributing to its increasing prevalence. This study aimed to analyze the underlying risk factors that contribute to the development of VIN, identify specific populations at risk, and define appropriate treatment approaches. Differentiated VIN (dVIN) and usual VIN (uVIN) are the classifications of VIN. While dVIN is associated with other vulvar inflammatory disorders, such as lichen sclerosis, the more prevalent uVIN is associated with an underlying human papillomavirus infection. Patients with differentiated VIN have an increased risk of developing invasive malignancies. Few effective surveillance or management techniques exist for vulvar intraepithelial neoplasia, a preinvasive neoplasm of the vulva. For suspicious lesions, a thorough examination and focused biopsy are necessary. Depending on the specific needs of each patient, a combination of surgical and medical approaches can be used.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948211/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139543094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Additional low-pressure pulmonary recruitment for reducing post-laparoscopic shoulder pain in gynecologic laparoscopy: a randomized controlled trial. 减少妇科腹腔镜手术后肩部疼痛的额外低压肺募集:随机对照试验。
IF 1.9 Q2 Medicine Pub Date : 2024-03-01 Epub Date: 2024-01-18 DOI: 10.5468/ogs.23197
Amornrat Temtanakitpaisan, Teerayut Temtanakitpaisan, Chaiyaporn Pratipanawatr, Pranom Buppasiri, Monsicha Somjit

Objective: To evaluate the effectiveness of additional low-pressure pulmonary recruitment in reducing postoperative shoulder pain.

Methods: A double-blind randomized controlled trial was conducted at Srinagarind Hospital between May 2021 and October 2021. Forty patients who underwent laparoscopic gynecologic surgery were randomized into either an intervention group that received additional low-pressure pulmonary recruitment (30 cmH2O) (n=20) or a control group (n=20). Shoulder pain was evaluated using a numerical rating scale from 0 to 10, 24, and 48 hours after the operation.

Results: The mean±standard deviation of shoulder pain at 24 hours after the operation of both the intervention and control groups were 2.10±2.27 and 1.45±1.73 points, respectively. The shoulder pain at 48 hours after the operation of the intervention and control groups were 1.15±1.46 and 0.85±1.73 points, respectively. There were no statistical differences in the mean difference between the two groups at 24 and 48 hours after operation (P=0.49; 95% confidence interval [CI], -0.61 to 1.91 and P=1.00; 95% CI, -0.96 to 1.56, respectively). No statistically significant differences were observed in additional analgesic medications used in either group, such as intravenous morphine or oral acetaminophen.

Conclusion: Additional low-pressure pulmonary recruitment to reduce shoulder pain after laparoscopic surgery for benign gynecologic diseases did not show a significant benefit compared to the control group, especially when administering postoperative around-the-clock analgesia.

目的评估额外的低压肺招募对减轻术后肩部疼痛的效果:2021 年 5 月至 2021 年 10 月期间,大学医院开展了一项双盲随机对照试验。40名接受腹腔镜妇科手术的患者被随机分为干预组(20人)和对照组(20人),干预组接受额外的低压肺通气(30 cmH2O)。术后24小时和48小时,采用0至10分的数字评分表对肩部疼痛进行评估:干预组和对照组术后 24 小时肩痛的平均值(标准差)分别为 2.10±2.27 分和 1.45±1.73 分。干预组和对照组术后 48 小时肩痛的平均值(1.15±1.46)分和标准差(0.85±1.73)分分别为(2.10±2.27)分和(1.45±1.73)分。两组在术后 24 小时和 48 小时的平均差异无统计学意义(P=0.49,95% 置信区间[CI],分别为-0.61 至 1.91 和 P=1.00,95% CI,-0.96 至 1.56)。两组额外使用的镇痛药物(如静脉注射吗啡或口服对乙酰氨基酚)在统计学上无明显差异:结论:与对照组相比,为减轻妇科良性疾病腹腔镜手术后肩部疼痛而进行的额外低压肺通气并未显示出明显的益处,尤其是在术后全天候镇痛的情况下。
{"title":"Additional low-pressure pulmonary recruitment for reducing post-laparoscopic shoulder pain in gynecologic laparoscopy: a randomized controlled trial.","authors":"Amornrat Temtanakitpaisan, Teerayut Temtanakitpaisan, Chaiyaporn Pratipanawatr, Pranom Buppasiri, Monsicha Somjit","doi":"10.5468/ogs.23197","DOIUrl":"10.5468/ogs.23197","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effectiveness of additional low-pressure pulmonary recruitment in reducing postoperative shoulder pain.</p><p><strong>Methods: </strong>A double-blind randomized controlled trial was conducted at Srinagarind Hospital between May 2021 and October 2021. Forty patients who underwent laparoscopic gynecologic surgery were randomized into either an intervention group that received additional low-pressure pulmonary recruitment (30 cmH2O) (n=20) or a control group (n=20). Shoulder pain was evaluated using a numerical rating scale from 0 to 10, 24, and 48 hours after the operation.</p><p><strong>Results: </strong>The mean±standard deviation of shoulder pain at 24 hours after the operation of both the intervention and control groups were 2.10±2.27 and 1.45±1.73 points, respectively. The shoulder pain at 48 hours after the operation of the intervention and control groups were 1.15±1.46 and 0.85±1.73 points, respectively. There were no statistical differences in the mean difference between the two groups at 24 and 48 hours after operation (P=0.49; 95% confidence interval [CI], -0.61 to 1.91 and P=1.00; 95% CI, -0.96 to 1.56, respectively). No statistically significant differences were observed in additional analgesic medications used in either group, such as intravenous morphine or oral acetaminophen.</p><p><strong>Conclusion: </strong>Additional low-pressure pulmonary recruitment to reduce shoulder pain after laparoscopic surgery for benign gynecologic diseases did not show a significant benefit compared to the control group, especially when administering postoperative around-the-clock analgesia.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139513493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy. 产科中的羟氯喹:妊娠期胎盘功能不全预防性使用羟氯喹的潜在影响》。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-03-01 Epub Date: 2024-01-19 DOI: 10.5468/ogs.23252
Yoo-Min Kim, Ji-Hee Sung, Hyun-Hwa Cha, Soo-Young Oh

Proper placentation during early pregnancy is a key factor for maintaining a healthy pregnancy. Placental insufficiency leads to critical complications such as preeclampsia, fetal growth restriction, and fetal demise. These complications are often associated with pathological findings of restricted remodeling and obstructive lesions of the myometrial spiral arteries, which have high recurrence rates during subsequent pregnancies. Currently, there are no pharmacological interventions other than aspirin for the prevention of preeclampsia. Hydroxychloroquine (HCQ), a well-known antimalarial drug, reduces inflammatory and thrombotic changes in vessels. For decades, the use of HCQ for autoimmune diseases has resulted in the successful prevention of both arterial and venous thrombotic events and has been extended to the treatment of lupus and antiphospholipid antibody syndrome during pregnancy. HCQ reduces the risk of preeclampsia with lupus by up to 90%. Several recent studies have investigated whether HCQ improves pregnancy outcomes in women with a history of poor outcomes. In addition, in vitro and animal studies have demonstrated the beneficial effects of HCQ in improving endothelial dysfunction and alleviating hypertension and proteinuria. Therefore, we hypothesized that HCQ has the potential to attenuate the vascular inflammatory and thrombogenic pathways associated with placental insufficiency and conducted a multicenter clinical trial on the efficacy of combining aspirin with HCQ for pregnancies at high risk for preeclampsia in Korea. This study summarizes the potential effects of HCQ on pregnancies with placental insufficiency and the implications of HCQ treatment in the field of obstetrics.

孕早期适当的胎盘植入是维持孕期健康的关键因素。胎盘功能不全可导致子痫前期、胎儿生长受限和胎儿死亡等严重并发症。这些并发症通常与子宫肌层螺旋动脉重塑受限和阻塞性病变的病理结果有关,这些病变在以后的妊娠中复发率很高。目前,除阿司匹林外,还没有其他药物干预措施来预防子痫前期。羟氯喹(HCQ)是一种著名的抗疟药物,可减少血管的炎症和血栓变化。几十年来,使用 HCQ 治疗自身免疫性疾病已成功预防了动脉和静脉血栓事件,并已扩展到治疗妊娠期狼疮和抗磷脂抗体综合征。HCQ 可将狼疮先兆子痫的风险降低高达 90%。最近有几项研究调查了 HCQ 是否能改善有不良妊娠结局病史的妇女的妊娠结局。此外,体外和动物实验也证明了 HCQ 在改善内皮功能障碍、缓解高血压和蛋白尿方面的有益作用。因此,我们假设 HCQ 有可能减轻与胎盘功能不全相关的血管炎症和血栓形成途径,并在韩国开展了一项多中心临床试验,研究阿司匹林与 HCQ 联合使用对子痫前期高危妊娠的疗效。本研究总结了 HCQ 对胎盘功能不全妊娠的潜在影响,以及 HCQ 治疗在产科领域的意义。
{"title":"Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy.","authors":"Yoo-Min Kim, Ji-Hee Sung, Hyun-Hwa Cha, Soo-Young Oh","doi":"10.5468/ogs.23252","DOIUrl":"10.5468/ogs.23252","url":null,"abstract":"<p><p>Proper placentation during early pregnancy is a key factor for maintaining a healthy pregnancy. Placental insufficiency leads to critical complications such as preeclampsia, fetal growth restriction, and fetal demise. These complications are often associated with pathological findings of restricted remodeling and obstructive lesions of the myometrial spiral arteries, which have high recurrence rates during subsequent pregnancies. Currently, there are no pharmacological interventions other than aspirin for the prevention of preeclampsia. Hydroxychloroquine (HCQ), a well-known antimalarial drug, reduces inflammatory and thrombotic changes in vessels. For decades, the use of HCQ for autoimmune diseases has resulted in the successful prevention of both arterial and venous thrombotic events and has been extended to the treatment of lupus and antiphospholipid antibody syndrome during pregnancy. HCQ reduces the risk of preeclampsia with lupus by up to 90%. Several recent studies have investigated whether HCQ improves pregnancy outcomes in women with a history of poor outcomes. In addition, in vitro and animal studies have demonstrated the beneficial effects of HCQ in improving endothelial dysfunction and alleviating hypertension and proteinuria. Therefore, we hypothesized that HCQ has the potential to attenuate the vascular inflammatory and thrombogenic pathways associated with placental insufficiency and conducted a multicenter clinical trial on the efficacy of combining aspirin with HCQ for pregnancies at high risk for preeclampsia in Korea. This study summarizes the potential effects of HCQ on pregnancies with placental insufficiency and the implications of HCQ treatment in the field of obstetrics.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139513510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validity of ultrasound with color Doppler to differentiate between benign and malignant ovarian tumours. 用彩色多普勒超声波区分良性和恶性卵巢肿瘤的有效性。
IF 1.9 Q2 Medicine Pub Date : 2024-03-01 Epub Date: 2024-02-20 DOI: 10.5468/ogs.23072
Nina Mahale, Neeti Kumar, Ajit Mahale, Sonali Ullal, Merwyn Fernandes, Sonali Prabhu

Objective: To assess the utility of ultrasound and color Doppler and the Accuracy of International Ovarian Tumor Analysis (IOTA) group classification in the preoperative evaluation of ovarian neoplasms to assess benign or malignant histopathology in the diagnosis of ovarian tumors.

Methods: This observational longitudinal prospective analysis of 60 patients was performed over a period of 2 years (2017- 2019). The mean age of the patients was 43.75 years. Ultrasonography of ovarian masses were evaluated, and cancer antigen-125 (CA-125) levels were evaluated. Based on the IOTA classification, the B and M features of adnexal masses were studied. Color Doppler imaging was performed to evaluate the patterns of vascularity and indices.

Results: Sixty patients with 35 benign, 23 malignant, and two borderline lesions were included in the study. In malignant lesions, 17 women (73.9%) were above the age of 45. The CA-125 cut off was ≥35 internatioal units/mL. Based on the IOTA classification, 27/35 (77.1%) benign cases, were correctly identified as benign, 6/35 (17.1%) benign cases were incorrectly identified as malignant, and two (5.7%) were found to be inconclusive. In the malignant group, 17 of the 23 patients were identified as having malignancy. Color Doppler showed three (18.8%) benign tumors had a pulsatality index (PI) of <0.8 and 21 malignant tumors had a PI of <0.8. Four benign tumors had an resistive index (RI) of <0.6 and 100% of malignant tumors had an RI <0.6.

Conclusion: The IOTA classification is a reliable scoring system for adnexal masses, and color Doppler can help to minimize interobserver variation.

目的评估超声和彩色多普勒在卵巢肿瘤术前评估中的实用性,以及国际卵巢肿瘤分析(IOTA)组分类在卵巢肿瘤诊断中评估良性或恶性组织病理学的准确性:这项观察性纵向前瞻性分析对60名患者进行了为期2年(2017-2019年)的观察。患者的平均年龄为 43.75 岁。对卵巢肿块进行了超声波检查,并评估了癌抗原125(CA-125)水平。根据 IOTA 分类,研究了附件肿块的 B 和 M 特征。进行彩色多普勒成像以评估血管形态和指数:研究共纳入 60 例患者,其中良性病变 35 例,恶性病变 23 例,边缘病变 2 例。在恶性病变中,17 名(73.9%)女性年龄在 45 岁以上。CA-125 临界值≥35 国际单位/毫升。根据 IOTA 分级,27/35(77.1%)个良性病例被正确识别为良性,6/35(17.1%)个良性病例被错误识别为恶性,2(5.7%)个病例未确定。在恶性组中,23 例患者中有 17 例被确定为恶性肿瘤。彩色多普勒显示,3 例(18.8%)良性肿瘤的搏动指数(PI)为结论:IOTA 分类是一种可靠的附件肿块评分系统,彩色多普勒可帮助减少观察者之间的差异。
{"title":"Validity of ultrasound with color Doppler to differentiate between benign and malignant ovarian tumours.","authors":"Nina Mahale, Neeti Kumar, Ajit Mahale, Sonali Ullal, Merwyn Fernandes, Sonali Prabhu","doi":"10.5468/ogs.23072","DOIUrl":"10.5468/ogs.23072","url":null,"abstract":"<p><strong>Objective: </strong>To assess the utility of ultrasound and color Doppler and the Accuracy of International Ovarian Tumor Analysis (IOTA) group classification in the preoperative evaluation of ovarian neoplasms to assess benign or malignant histopathology in the diagnosis of ovarian tumors.</p><p><strong>Methods: </strong>This observational longitudinal prospective analysis of 60 patients was performed over a period of 2 years (2017- 2019). The mean age of the patients was 43.75 years. Ultrasonography of ovarian masses were evaluated, and cancer antigen-125 (CA-125) levels were evaluated. Based on the IOTA classification, the B and M features of adnexal masses were studied. Color Doppler imaging was performed to evaluate the patterns of vascularity and indices.</p><p><strong>Results: </strong>Sixty patients with 35 benign, 23 malignant, and two borderline lesions were included in the study. In malignant lesions, 17 women (73.9%) were above the age of 45. The CA-125 cut off was ≥35 internatioal units/mL. Based on the IOTA classification, 27/35 (77.1%) benign cases, were correctly identified as benign, 6/35 (17.1%) benign cases were incorrectly identified as malignant, and two (5.7%) were found to be inconclusive. In the malignant group, 17 of the 23 patients were identified as having malignancy. Color Doppler showed three (18.8%) benign tumors had a pulsatality index (PI) of <0.8 and 21 malignant tumors had a PI of <0.8. Four benign tumors had an resistive index (RI) of <0.6 and 100% of malignant tumors had an RI <0.6.</p><p><strong>Conclusion: </strong>The IOTA classification is a reliable scoring system for adnexal masses, and color Doppler can help to minimize interobserver variation.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139906628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advantages of laparoscopy in gynecologic surgery in elderly patients. 腹腔镜在老年妇科手术中的优势。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-03-01 Epub Date: 2023-12-06 DOI: 10.5468/ogs.23238
Jaewon Na, Young Eun Chung, Il-Yeo Jang, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Chi-Son Chang, Chel Hun Choi

Objective: Geriatric patients requiring gynecological surgery is increasing worldwide. However, older patients are at higher risk of postoperative morbidity and mortality, particularly cardiopulmonary complications. Laparoscopic surgery is widely used as a minimally invasive method for reducing postoperative morbidities. We compared the outcomes of open and laparoscopic gynecologic surgeries in patients older than 55 years.

Methods: We included patients aged >55 years who underwent gynecological surgery at a single tertiary center between 2010 and 2020, excluding vaginal or ovarian cancer surgeries were excluded. Surgical outcomes were compared between the open surgery and laparoscopic groups, with age cutoff was set at 65 years for optimal discriminative power. We performed linear or logistic regression analyses to compare the surgical outcomes according to age and operation type.

Results: Among 2,983 patients, 28.6% underwent open surgery and 71.4% underwent laparoscopic surgery. Perioperative outcomes of laparoscopic surgery were better than those of open surgery in all groups. In both the open and laparoscopic surgery groups, the older patients showed worse overall surgical outcomes. However, age-related differences in perioperative outcomes were less severe in the laparoscopic group. In the linear regression analysis, the differences in estimated blood loss, transfusion, and hospital stay between the age groups were smaller in the laparoscopy group. Similar restuls were observed in cancer-only and benign-only cohorts.

Conclusion: Although the surgical outcomes were worse in the older patients, the difference between age groups was smaller for laparoscopic surgery. Laparoscopic surgery offers more advantages and safety in patients aged >65 years.

目的:全世界需要进行妇科手术的老年患者越来越多。然而,老年患者术后发病和死亡的风险较高,尤其是心肺并发症。腹腔镜手术作为一种微创方法被广泛应用于降低术后发病率。我们比较了老年患者接受开腹和腹腔镜妇科手术的结果:我们纳入了 2010 年至 2020 年期间在一家三级医院接受妇科手术的 55 岁以上患者。排除了接受过阴道癌或卵巢癌手术的患者。比较了开放手术组和腹腔镜组的手术结果。年龄分界线设定为 65 岁,这表明年轻组和年长组之间的手术结果最有鉴别力。我们根据年龄和手术类型进行了线性或逻辑回归分析,以比较手术结果:在2983名患者中,28.6%接受了开腹手术,71.4%接受了腹腔镜手术。在所有组别中,腹腔镜手术的围手术期疗效均优于开腹手术。在开腹手术组和腹腔镜手术组中,年龄较大的患者总体手术效果较差。然而,腹腔镜手术组围手术期结果与年龄有关的差异较小。在线性回归分析中,腹腔镜手术组的估计失血量、输血量和住院时间在不同年龄组之间的差异较小。纯癌症组和纯良性组的结果相似:结论:虽然老年患者的手术效果较差,但腹腔镜手术的年龄组间差异较小。腹腔镜手术对年龄大于65岁的患者更具优势和安全性。
{"title":"Advantages of laparoscopy in gynecologic surgery in elderly patients.","authors":"Jaewon Na, Young Eun Chung, Il-Yeo Jang, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Chi-Son Chang, Chel Hun Choi","doi":"10.5468/ogs.23238","DOIUrl":"10.5468/ogs.23238","url":null,"abstract":"<p><strong>Objective: </strong>Geriatric patients requiring gynecological surgery is increasing worldwide. However, older patients are at higher risk of postoperative morbidity and mortality, particularly cardiopulmonary complications. Laparoscopic surgery is widely used as a minimally invasive method for reducing postoperative morbidities. We compared the outcomes of open and laparoscopic gynecologic surgeries in patients older than 55 years.</p><p><strong>Methods: </strong>We included patients aged >55 years who underwent gynecological surgery at a single tertiary center between 2010 and 2020, excluding vaginal or ovarian cancer surgeries were excluded. Surgical outcomes were compared between the open surgery and laparoscopic groups, with age cutoff was set at 65 years for optimal discriminative power. We performed linear or logistic regression analyses to compare the surgical outcomes according to age and operation type.</p><p><strong>Results: </strong>Among 2,983 patients, 28.6% underwent open surgery and 71.4% underwent laparoscopic surgery. Perioperative outcomes of laparoscopic surgery were better than those of open surgery in all groups. In both the open and laparoscopic surgery groups, the older patients showed worse overall surgical outcomes. However, age-related differences in perioperative outcomes were less severe in the laparoscopic group. In the linear regression analysis, the differences in estimated blood loss, transfusion, and hospital stay between the age groups were smaller in the laparoscopy group. Similar restuls were observed in cancer-only and benign-only cohorts.</p><p><strong>Conclusion: </strong>Although the surgical outcomes were worse in the older patients, the difference between age groups was smaller for laparoscopic surgery. Laparoscopic surgery offers more advantages and safety in patients aged >65 years.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138488635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of antioxidant supplementation on dysmenorrhea and endometriosis-associated painful symptoms: a systematic review and meta-analysis of randomized clinical trials. 抗氧化剂补充剂对痛经和子宫内膜异位症相关疼痛症状的影响:随机临床试验的系统回顾和荟萃分析。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-03-01 Epub Date: 2024-01-15 DOI: 10.5468/ogs.23210
Saeed Baradwan, Abdulrahim Gari, Hussein Sabban, Majed Saeed Alshahrani, Khalid Khadawardi, Ibtihal Abdulaziz Bukhari, Abdullah Alyousef, Ahmed Abu-Zaid

This study aimed to review randomized controlled trials (RCTs) investigating the effects of dietary antioxidant supplements on the severity of endometriosis-related pain symptoms. The PubMed/Medline, Scopus, and Web of Science databases were searched until April 2022. Additionally, we manually searched the reference lists. Endpoints were summarized as standardized mean difference (SMD) with 95% confidence intervals (CIs) in a random-effects model. The I2 statistic was used to assess heterogeneity. Ten RCTs were included in this meta-analysis. Overall, 10 studies were related to dysmenorrhea, four to dyspareunia, and four to pelvic pain. Antioxidants significantly reduced dysmenorrhea (SMD, -0.48; 95% CI, -0.82 to -0.13; I2=75.14%). In a subgroup analysis, a significant reduction of dysmenorrhea was observed only in a subset of trials that administered vitamin D (SMD, -0.59; 95% CI, -1.13 to -0.06; I2=69.59%) and melatonin (SMD, -1.40; 95% CI, -2.47 to -0.32; I2=79.15%). Meta-analysis results also suggested that antioxidant supplementation significantly improved pelvic pain (SMD, -1.51; 95% CI, -2.74 to -0.29; I2=93.96%), although they seem not to have a significant beneficial impact on the severity of dyspareunia. Dietary antioxidant supplementation seems to beneficially impact the severity of endometriosis-related dysmenorrhea (with an emphasis on vitamin D and melatonin) and pelvic pain. However, due to the relatively small sample size and high heterogeneity, the findings should be interpreted cautiously, and the importance of further well-designed clinical studies cannot be overstated.

本研究旨在回顾调查膳食抗氧化剂补充剂对子宫内膜异位症相关疼痛症状严重程度影响的随机对照试验(RCT)。我们检索了 PubMed/Medline、Scopus 和 Web of Science 数据库,检索时间截止到 2022 年 4 月。此外,我们还人工检索了参考文献列表。在随机效应模型中,终点以标准化均值差异(SMD)和95%置信区间(CI)进行总结。I2统计量用于评估异质性。本次荟萃分析共纳入了 10 项研究。总体而言,10 项研究与痛经有关,4 项研究与排便困难有关,4 项研究与盆腔疼痛有关。抗氧化剂可明显减少痛经(SMD,-0.48;95% CI,-0.82 至 -0.13;I2=75.14%)。在一项亚组分析中,仅在服用维生素 D(SMD,-0.59;95% CI,-1.13 至 -0.06;I2=69.59%)和褪黑素(SMD,-1.40;95% CI,-2.47 至 -0.32;I2=79.15%)的试验中观察到痛经明显减少。元分析结果还表明,补充抗氧化剂可明显改善骨盆疼痛(SMD,-1.51;95% CI,-2.74 至 -0.29;I2=93.96%),尽管它们似乎对排便困难的严重程度没有显著的有益影响。补充膳食抗氧化剂似乎对子宫内膜异位症相关痛经(重点是维生素 D 和褪黑激素)和盆腔疼痛的严重程度有好处。然而,由于样本量相对较小,异质性较高,因此应谨慎解读研究结果,进一步开展设计良好的临床研究的重要性无论如何强调都不为过。
{"title":"The effect of antioxidant supplementation on dysmenorrhea and endometriosis-associated painful symptoms: a systematic review and meta-analysis of randomized clinical trials.","authors":"Saeed Baradwan, Abdulrahim Gari, Hussein Sabban, Majed Saeed Alshahrani, Khalid Khadawardi, Ibtihal Abdulaziz Bukhari, Abdullah Alyousef, Ahmed Abu-Zaid","doi":"10.5468/ogs.23210","DOIUrl":"10.5468/ogs.23210","url":null,"abstract":"<p><p>This study aimed to review randomized controlled trials (RCTs) investigating the effects of dietary antioxidant supplements on the severity of endometriosis-related pain symptoms. The PubMed/Medline, Scopus, and Web of Science databases were searched until April 2022. Additionally, we manually searched the reference lists. Endpoints were summarized as standardized mean difference (SMD) with 95% confidence intervals (CIs) in a random-effects model. The I2 statistic was used to assess heterogeneity. Ten RCTs were included in this meta-analysis. Overall, 10 studies were related to dysmenorrhea, four to dyspareunia, and four to pelvic pain. Antioxidants significantly reduced dysmenorrhea (SMD, -0.48; 95% CI, -0.82 to -0.13; I2=75.14%). In a subgroup analysis, a significant reduction of dysmenorrhea was observed only in a subset of trials that administered vitamin D (SMD, -0.59; 95% CI, -1.13 to -0.06; I2=69.59%) and melatonin (SMD, -1.40; 95% CI, -2.47 to -0.32; I2=79.15%). Meta-analysis results also suggested that antioxidant supplementation significantly improved pelvic pain (SMD, -1.51; 95% CI, -2.74 to -0.29; I2=93.96%), although they seem not to have a significant beneficial impact on the severity of dyspareunia. Dietary antioxidant supplementation seems to beneficially impact the severity of endometriosis-related dysmenorrhea (with an emphasis on vitamin D and melatonin) and pelvic pain. However, due to the relatively small sample size and high heterogeneity, the findings should be interpreted cautiously, and the importance of further well-designed clinical studies cannot be overstated.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139466941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fetomaternal outcomes in pregnant women with congenital heart disease: a comparative analysis from an apex institute. 患有先天性心脏病的孕妇的孕产妇结局:来自顶级研究所的对比分析。
IF 1.9 Q2 Medicine Pub Date : 2024-03-01 Epub Date: 2024-02-15 DOI: 10.5468/ogs.23264
Soniya Dhiman, Aparna Sharma, Akanksha Gupta, Richa Vatsa, Juhi Bharti, Vidushi Kulshrestha, Satyavir Yadav, Vatsla Dadhwal, Neena Malhotra

Objective: With advancements in cardiac surgical interventions during infancy and childhood, the incidence of maternal congenital heart disease (CHD) is increasing. This retrospective study compared fetal and cardiac outcomes in women with and without CHD, along with a sub-analysis between cyanotic versus non-cyanotic defects and operated versus non-operated cases.

Methods: A 10-year data were retrospectively collected from pregnant women with CHD and a 1:1 ratio of pregnant women without any heart disease. Adverse fetal and cardiac outcomes were noted in both groups. Statistical significance was set at P<0.05.

Results: A total of 86 pregnant women with CHD were studied, with atrial septal defects (29.06%) being the most common. Out of 86 participants, 27 (31.39%) had cyanotic CHD. Around 55% of cases were already operated on for their cardiac defects. Among cardiovascular complications, 5.8% suffered from heart failure, 7.0% had pulmonary arterial hypertension, 8.1% presented in New York Heart Association functional class IV, 9.3% had a need for intensive care unit admission, and one experienced maternal mortality. Adverse fetal outcomes, including operative vaginal delivery, mean duration of hospital stay, fetal growth restriction, preterm birth (<37 weeks), low birth weight (<2,500 g), 5-minute APGAR score <7, and neonatal intensive care unit admissions, were significantly higher in women with CHD than in women without heart disease.

Conclusion: Women with CHD have a higher risk of adverse fetal and cardiac outcomes. The outcome can be improved with proper pre-conceptional optimization of the cardiac condition, good antenatal care, and multidisciplinary team management.

目的:随着婴幼儿时期心脏外科干预技术的进步,孕产妇先天性心脏病(CHD)的发病率也在增加。这项回顾性研究比较了患有和未患有先天性心脏病的孕妇的胎儿和心脏预后,并对发绀与非发绀缺陷、手术与非手术病例进行了子分析:回顾性收集了患有先天性心脏病的孕妇和未患有任何心脏病的孕妇的 10 年数据,两者的比例为 1:1。两组孕妇的胎儿和心脏均出现不良后果。统计显著性以PR结果为标准:共对 86 名患有先天性心脏病的孕妇进行了研究,其中最常见的是房间隔缺损(29.06%)。在 86 名参与者中,27 人(31.39%)患有发绀性先天性心脏病。约 55% 的病例曾因心脏缺陷接受过手术。在心血管并发症中,5.8%患有心力衰竭,7.0%患有肺动脉高压,8.1%属于NYHA功能分级IV级,9.3%需要入住重症监护室,1名产妇死亡。胎儿的不良结局包括阴道分娩手术、平均住院时间、胎儿生长受限、早产(结论:患有先天性心脏病的妇女有更高的风险:患有先天性心脏病的妇女出现胎儿和心脏不良预后的风险较高。通过适当的孕前心脏状况优化、良好的产前护理和多学科团队管理,可以改善预后。
{"title":"Fetomaternal outcomes in pregnant women with congenital heart disease: a comparative analysis from an apex institute.","authors":"Soniya Dhiman, Aparna Sharma, Akanksha Gupta, Richa Vatsa, Juhi Bharti, Vidushi Kulshrestha, Satyavir Yadav, Vatsla Dadhwal, Neena Malhotra","doi":"10.5468/ogs.23264","DOIUrl":"10.5468/ogs.23264","url":null,"abstract":"<p><strong>Objective: </strong>With advancements in cardiac surgical interventions during infancy and childhood, the incidence of maternal congenital heart disease (CHD) is increasing. This retrospective study compared fetal and cardiac outcomes in women with and without CHD, along with a sub-analysis between cyanotic versus non-cyanotic defects and operated versus non-operated cases.</p><p><strong>Methods: </strong>A 10-year data were retrospectively collected from pregnant women with CHD and a 1:1 ratio of pregnant women without any heart disease. Adverse fetal and cardiac outcomes were noted in both groups. Statistical significance was set at P<0.05.</p><p><strong>Results: </strong>A total of 86 pregnant women with CHD were studied, with atrial septal defects (29.06%) being the most common. Out of 86 participants, 27 (31.39%) had cyanotic CHD. Around 55% of cases were already operated on for their cardiac defects. Among cardiovascular complications, 5.8% suffered from heart failure, 7.0% had pulmonary arterial hypertension, 8.1% presented in New York Heart Association functional class IV, 9.3% had a need for intensive care unit admission, and one experienced maternal mortality. Adverse fetal outcomes, including operative vaginal delivery, mean duration of hospital stay, fetal growth restriction, preterm birth (<37 weeks), low birth weight (<2,500 g), 5-minute APGAR score <7, and neonatal intensive care unit admissions, were significantly higher in women with CHD than in women without heart disease.</p><p><strong>Conclusion: </strong>Women with CHD have a higher risk of adverse fetal and cardiac outcomes. The outcome can be improved with proper pre-conceptional optimization of the cardiac condition, good antenatal care, and multidisciplinary team management.</p>","PeriodicalId":37602,"journal":{"name":"Obstetrics and Gynecology Science","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139736355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obstetrics and Gynecology Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1